Published in Ned Tijdschr Geneeskd on October 08, 2005
[Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept]. Ned Tijdschr Geneeskd (2005) 1.39
[Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis]. Ned Tijdschr Geneeskd (2006) 0.75
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis (2010) 6.75
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet (1992) 4.15
High frequency of early colorectal cancer in inflammatory bowel disease. Gut (2008) 3.46
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Mortality in hereditary antithrombin-III deficiency--1830 to 1989. Lancet (1991) 2.31
Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut (2008) 2.06
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy (2007) 1.60
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients. Clin Endocrinol (Oxf) (2000) 1.53
Review article: thiopurines in inflammatory bowel disease. Aliment Pharmacol Ther (2006) 1.32
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease. J Crohns Colitis (2012) 1.15
Rage signalling promotes intestinal tumourigenesis. Oncogene (2012) 1.11
Tissue level, activation and cellular localisation of TGF-beta1 and association with survival in gastric cancer patients. Br J Cancer (2007) 1.09
Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflamm Bowel Dis (2010) 1.00
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther (2013) 0.97
Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype. Dig Liver Dis (2007) 0.97
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer (2009) 0.96
New cytokine therapeutics for inflammatory bowel disease. Cytokine (2004) 0.94
Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays. Thromb Haemost (1994) 0.91
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not. Br J Cancer (2008) 0.90
MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients. Br J Cancer (2012) 0.88
Transforming growth factor alpha in Ménétrier's disease. J Pediatr Gastroenterol Nutr (1993) 0.87
Fish oil for induction of remission in ulcerative colitis. Cochrane Database Syst Rev (2007) 0.86
Acromegaly is associated with an increased prevalence of colonic diverticula: a case-control study. J Clin Endocrinol Metab (2010) 0.86
Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. Br J Surg (2007) 0.84
Stem cells as potential novel therapeutic strategy for inflammatory bowel disease. J Crohns Colitis (2008) 0.84
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol (1996) 0.83
Recurrence after segmental resection for colonic Crohn's disease. Br J Surg (2005) 0.83
More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis. Inflamm Bowel Dis (2009) 0.82
Clinical significance of stromal apoptosis in colorectal cancer. Br J Cancer (2009) 0.80
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (1995) 0.79
Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes (1997) 0.79
[Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease]. Ned Tijdschr Geneeskd (2005) 0.79
Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scand J Clin Lab Invest (1997) 0.79
NOD2 in Crohn's disease--loss or gain of function mutations? Neth J Med (2005) 0.78
Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Aliment Pharmacol Ther (2006) 0.78
Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease. Dig Liver Dis (2006) 0.78
Anti-TNF and Crohn's disease: when should we start? Curr Drug Targets (2010) 0.78
Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist. Scand J Gastroenterol (1996) 0.77
Plasma semicarbazide-sensitive amine oxidase is moderately decreased by pronounced exogenous hyperinsulinemia but is not associated with insulin sensitivity and body fat. Scand J Clin Lab Invest (2006) 0.77
Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox. Scand J Clin Lab Invest (2005) 0.77
Magnetic resonance imaging of the hand joints in patients with inflammatory bowel disease and arthralgia: a pilot study. Scand J Rheumatol (2014) 0.77
Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practice. Aliment Pharmacol Ther (2007) 0.77
Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Invest (1999) 0.77
The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly. J Clin Endocrinol Metab (2009) 0.77
Therapeutic modulation of signal transduction pathways. Inflamm Bowel Dis (2004) 0.76
Effect of insulin on apolipoprotein(a) synthesis. Diabetologia (1999) 0.75
Regulation of T-cell differentiation by CD2 and CD28 accessory molecules. Immunology (1991) 0.75
Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients. Gut (2008) 0.75
Genetic basis of Alagille syndrome deciphered. J Pediatr Gastroenterol Nutr (1998) 0.75
First endoscopic appearance of ulcerative colitis. J Crohns Colitis (2008) 0.75
High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men. Scand J Clin Lab Invest (1998) 0.75
Vitamin B12 and bile acid metabolism in patients with partial iieal resection. Digestion (1977) 0.75
[Can nearly finished medical students interpret their professional literature?]. Ned Tijdschr Geneeskd (1990) 0.75
Expression of homeobox genes in the gastrointestinal tract. J Pediatr Gastroenterol Nutr (1998) 0.75